FDA Inspection 1243167 — Keyvan Karkouti, M.D.
The FDA completed an inspection of Keyvan Karkouti, M.D. on Jun 7, 2024 in Toronto. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 7, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Toronto (Canada)
Additional Details
Clinical Investigator (CI)